Bazedoxifene/conjugated estrogens

Bazedoxifene/conjugated estrogens, sold under the brand name Duavee in the US and Duavive in the EU, is a fixed-dose combination medication for the treatment of menopause symptoms and postmenopausal osteoporosis.[2] It contains the selective estrogen receptor modulator bazedoxifene and conjugated estrogens. It is taken by mouth.

Bazedoxifene/conjugated estrogens
Combination of
BazedoxifeneSelective estrogen receptor modulator
Conjugated estrogensEstrogen
Clinical data
Trade namesDuavee, Duavive
AHFS/Drugs.comProfessional Drug Facts
MedlinePlusa614004
License data
Pregnancy
category
    Routes of
    administration
    By mouth
    ATC code
    Legal status
    Legal status
    • US: ℞-only
    • In general: ℞ (Prescription only)
    Identifiers
    ChemSpider
    • None
    KEGG

    The combination was approved for medical use in the United States in October 2013,[3] and in the European Union in December 2014.[4]

    Recall

    In June 2020, Pfizer recalled recalled two batches of Duavive, its oestrogen replacement product, as a result of concerns raised about faulty packaging.[5]

    gollark: I'm thinking:- SHA256- some somewhat sensible password hashing function- ChaCha20/AES256- ECC stuff
    gollark: Yes. People often ask "how do I do [some crypto operation]" so just point them to it.
    gollark: Well, we could probably convince people to use it quite easily.
    gollark: Supporting common stuff like hashing, maybe a more secure (P)RNG, and symmetric/asymmetric encryption.
    gollark: Also, we could really use a unified CC crypto library instead of every program randomly pulling in their own possibly broken versions.

    See also

    References


    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.